Prevalence of the most frequent BRCA1 mutations in Polish population

Journal of Applied Genetics

Volumn 52, Issue 3, 2011, Pages 325-330

  Brozek, Izabela ^a   Cybulska, Celina ^a   Ratajska, Magdalena ^a   Piatkowska, Magdalena ^b   Kluska, Anna ^b   Balabas, Aneta ^b   Dabrowska, Michalina ^b   Nowakowska, Dorota ^b   Niwinska, Anna ^b   Pamula Pilat, Jolanta ^c   Tecza, Karolina ^c   Pekala, Wioletta ^c   Rembowska, Jolanta ^d   Nowicka, Karina ^d   Mosor, Maria ^d   Januszkiewicz Lewandowska, Danuta ^d   Rachtan, Jadwiga ^e   Grzybowska, Ewa ^c   Nowak, Jerzy ^d   Steffen, Jan ^b   Limon, Janusz ^a   more..

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d INSTITUTE OF HUMAN GENETICS   (Poland)

^e INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

BRCA1 in Poland; BRCA1 mutations; Hereditary breast cancer

Indexed keywords

BRCA1 PROTEIN; DNA;

ALLELE; ARTICLE; BREAST TUMOR; CAUCASIAN; DNA SEQUENCE; EXON; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MUTATION; OVARY TUMOR; POLAND; PREVALENCE; TUMOR SUPPRESSOR GENE;

ALLELES; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENE FREQUENCY; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OVARIAN NEOPLASMS; POLAND; PREVALENCE; SEQUENCE ANALYSIS, DNA;

EID: 79960078862     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-011-0040-6     Document Type: Article

References (36)

1. Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J et al. (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86: 76-83.
2. Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL et al. (2005) Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 42: 602-603.
3. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94: 1365-1372.
4. Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M et al. (2008) High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland. Gynecol Oncol 108: 433-437.
5. Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M et al. (2009) Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers. J Appl Genet 50: 379-384.
6. Csokay B, Tihomirova L, Stengrevics A, Sinicka O, Olah E (1999) Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Hum Mutat 14: 92.
7. Elsakov P, Kurtinaitis J, Petraitis S, Ostapenko V, Razumas M, Razumas T et al. (2010) The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania. Clin Genet 78: 373-376.
8. Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Suppl 6 et al. (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18: vi93-vi98.
9. Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI et al. (1998) Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 63: 45-51.
10. Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57: 1457-1462.
11. Foretova L, Machackova E, Navratilova M, Pavlu H, Hruba M, Lukesova M, Valik D (2004) BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic. Hum Mutat 23: 397-398.
12. Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A et al. (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92: 19-24.
13. Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J et al. (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66: 1963-1968.
14. Grzybowska E, Zientek H, Jasinska A, Rusin M, Kozlowski P, Sobczak K et al. (2000) High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16: 482-490.
15. Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C et al. (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115: 2222-2233, Erratum in: Cancer 115: 2804.
16. Janiszewska H, Haus O, Lauda-Swieciak A, Pasinska M, Laskowski R, Szymański W et al. (2003) Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland. Clin Genet 64: 502-508.
17. Jasinska A, Krzyzosiak WJ (2001) Prevalence of BRCA1 founder mutations in western Poland. Hum Mutat 17: 75.
18. John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP et al. (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298: 2869-2876.
19. Kroiss R, Winkler V, Bikas D, Fleischmann E, Mainau C, Frommlet F et al. (2005) Austrian Hereditary Breast and Ovarian Cancer Group. Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers. Hum Mutat 26: 583-589.
20. Kurian AW (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22: 72-78.
21. Loginova AN, Pospekhova NI, Lyubchenko LN, Budilov AV, Zakhar'ev VM, Gar'kavtseva RF et al. (2003) Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families. Bull Exp Biol Med 136: 276-278.
22. Machackova E, Foretova L, Lukesova M, Vasickova P, Navratilova M, Coene I et al. (2008) Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer. BMC Cancer 8: 140.
23. Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ et al. (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women, ages 35 to 64 years. Cancer Res 66: 8297-8308.
24. Meindl A, German Consortium for Hereditary Breast and Ovarian Cancer (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97: 472-480.
25. Metcalfe KA, Poll A, Royer R, Llacuachaqui M, Tulman A, Sun P, Narod SA (2010) Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 28: 387-391.
26. Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W et al. (2009) BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Family Registry. Breast Cancer Res Treat 116: 379-386.
27. Perkowska M, Brozek I, Wysocka B, Haraldsson K, Sandberg T, Johansson U et al. (2003) BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from north-eastern Poland. Hum Mutat 21: 553-554.
28. Ploski R, Wozniak M, Pawlowski R, Monies DM, Branicki W, Kupiec T et al. (2002) Homogeneity and distinctiveness of Polish paternal lineages revealed by Y chromosome microsatellite haplotype analysis. Hum Genet 110: 592-600.
29. Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G et al. (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19: 263-268.
30. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I et al. (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98: 1694-1706.
31. Sokolenko AP, Mitiushkina NV, Buslov KG, Bit-Sava EM, Iyevleva AG, Chekmariova EV et al. (2006) High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer 42: 1380-1384.
32. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M et al. (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408.
33. van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E (2000a) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15: 480-487.
34. van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T et al. (2000b) Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86: 737-740.
35. Whittemore AS, Gong G, Itnyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U. S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60: 496-504.
36. Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL et al. (2004) Prevalence of BRCA1 mutation carriers among U. S. non-Hispanic Whites. Cancer Epidemiol Biomark Prev 13: 2078-2083.